| 今开：25.15 | 昨收：24.76 |
| 最高：26.27 | 最低：24.61 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.16795626E9 |
产业链观察03-15 00:14
#药闻简讯# 美国FDA已批准$Mirum制药(MIRM)$ LIVMARLI（maralixibat）口服溶液用于治疗5岁及以上进行性家族性肝内胆汁淤积症（PFIC）患者的胆汁淤积性瘙痒。查看全文
Mirum(MIRM)03-16 05:15
$Mirum制药(MIRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032289 Act: 34 Size: 15 MB 网页链接查看全文
Mirum(MIRM)03-26 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接查看全文
Mirum(MIRM)04-24 04:35
$Mirum(MIRM)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-021367 Act: 34 Size: 1 MB 网页链接查看全文
Mirum(MIRM)03-19 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008311 Size: 4 KB 网页链接查看全文
Mirum(MIRM)03-19 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008316 Size: 6 KB 网页链接查看全文
Mirum(MIRM)02-14 06:15
$Mirum制药(MIRM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-021478 Act: 34 Size: 13 KB 网页链接查看全文
Mirum(MIRM)02-29 05:15
$Mirum制药(MIRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001759425-24-000005 Act: 34 Size: 287 KB 网页链接查看全文
Mirum(MIRM)03-19 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008313 Size: 5 KB 网页链接查看全文
Mirum(MIRM)02-15 01:55
$Mirum制药(MIRM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001580642-24-000990 Act: 34 Size: 56 KB 网页链接查看全文
chuminhua2019-10-29 11:18
10/28，Mirum Pharmaceuticals公司$Mirum制药(MIRM)$ 宣布，美国FDA授予其选择性ASBT抑制剂maralixibat突破性疗法认定，用于治疗1岁及以上Alagille综合症（ALGS）儿童患者的瘙痒症状。该疗法在治疗ALGS儿童患者的2b期临床试验中，显著降低了患者的血清胆汁酸（sBA）水平，并改善患者的瘙痒症状。此...查看全文
$Mirum(MIRM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001759425-24-000019 Act: 34 Size: 6 MB 网页链接
$Mirum(MIRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001759425-24-000017 Act: 34 Size: 255 KB 网页链接
$Mirum(MIRM)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-021367 Act: 34 Size: 1 MB 网页链接
$Mirum(MIRM)$ DEF 14A Other definitive proxy statements Accession Number: 0001759425-24-000011 Act: 34 Size: 1 MB 网页链接
$Mirum(MIRM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001759425-24-000012 Act: 34 Size: 458 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009280 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008320 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008322 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008311 Size: 4 KB 网页链接